Dual regulation effect and mechanism of human myeloid‐derived suppressor cells on anticolorectal cancer cells activity of Vγ9Vδ2 T cells.

Myeloid‐derived suppressor cells (MDSC) are a group of immature inhibitory cells of bone marrow origin. Human γδ T cells (mainly Vγ9Vδ2 T cells) have emerged as dominant candidates for cancer immunotherapy because of their unique recognition pattern and broad killing activity against tumor cells. Intestinal mucosal intraepithelial lymphocytes are almost exclusively γδ T cells, so it plays an important role in inhibiting the development of colorectal cancer. In this study, we investigated the effects and molecular mechanism of human MDSC on anticolorectal cancer cells activity of Vγ9Vδ2 T cells. Our results suggested that MDSC can reduce the NKG2D expression of Vγ9Vδ2 T cells through direct cell–cell contact, which is associated with membrane‐type transforming growth factor‐β. In contrast, MDSC can increase Vγ9Vδ2 T cells activation and production of IFN‐γ, perforin, Granzyme B through direct cell–cell contact. This may be related to the upregulation of T‐bet in Vγ9Vδ2 T cells by MDSC. However, MDSC had a dominant negative regulatory effect on the anticolorectal cancer cells activity of Vγ9Vδ2 T cells. Our study provides a theoretical basis for the immune regulatory function of human MDSC on γδ T cells. This will be conducive to the clinical development of a new antitumor therapy strategy. Significance statement: In this study, we found e‐myeloid‐derived suppressor cells (e‐MDSC) is the majority of MDSC differentiated in vitro. These MDSC can reduce the NKG2D expression of Vγ9Vδ2 T cells through direct cell–cell contact, which is associated with membrane‐type transforming growth factor‐β. In contrast, MDSC can increase Vγ9Vδ2 T cells activation and production of IFN‐γ, perforin, Granzyme B through direct cell–cell contact. This may be related to the upregulation of T‐bet in Vγ9Vδ2 T cells by MDSC. However, MDSC had a dominant negative regulatory effect on the anticolorectal cancer cells activity of Vγ9Vδ2 T cells. Our study provides a theoretical basis for the immune regulatory function of human MDSC on γδ T cells. This will be conducive to the clinical development of a new antitumor therapy strategy. [ABSTRACT FROM AUTHOR]